Dermapharm Holding SE (LON:0A5J)

Dermapharm Holding SE Statistics

Total Valuation

LON:0A5J has a market cap or net worth of GBP 1.53 billion. The enterprise value is 2.26 billion.

Market Cap	1.53B
Enterprise Value	2.26B

Important Dates

The next estimated earnings date is Thursday, November 13, 2025.

Earnings Date	Nov 13, 2025
Ex-Dividend Date	Jun 27, 2025

Share Statistics

Current Share Class	53.84M
Shares Outstanding	n/a
Shares Change (YoY)	-0.35%
Shares Change (QoQ)	-0.57%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	8.85M

Valuation Ratios

The trailing PE ratio is 16.60 and the forward PE ratio is 13.46.

PE Ratio	16.60
Forward PE	13.46
PS Ratio	1.49
PB Ratio	2.94
P/TBV Ratio	n/a
P/FCF Ratio	10.15
P/OCF Ratio	8.26
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.82, with an EV/FCF ratio of 15.05.

EV / Earnings	24.61
EV / Sales	2.18
EV / EBITDA	9.82
EV / EBIT	11.22
EV / FCF	15.05

Financial Position

The company has a current ratio of 1.84, with a Debt / Equity ratio of 1.67.

Current Ratio	1.84
Quick Ratio	0.78
Debt / Equity	1.67
Debt / EBITDA	3.84
Debt / FCF	5.76
Interest Coverage	4.30

Financial Efficiency

Return on equity (ROE) is 18.23% and return on invested capital (ROIC) is 8.84%.

Return on Equity (ROE)	18.23%
Return on Assets (ROA)	6.62%
Return on Invested Capital (ROIC)	8.84%
Return on Capital Employed (ROCE)	12.95%
Revenue Per Employee	287,496
Profits Per Employee	25,877
Employee Count	3,610
Asset Turnover	0.55
Inventory Turnover	1.24

Taxes

In the past 12 months, LON:0A5J has paid 49.41 million in taxes.

Income Tax	49.41M
Effective Tax Rate	35.24%

Stock Price Statistics

The stock price has decreased by -3.61% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-3.61%
50-Day Moving Average	33.25
200-Day Moving Average	36.56
Relative Strength Index (RSI)	37.52
Average Volume (20 Days)	13,725

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, LON:0A5J had revenue of GBP 1.02 billion and earned 91.89 million in profits. Earnings per share was 1.71.

Revenue	1.02B
Gross Profit	647.74M
Operating Income	197.08M
Pretax Income	140.19M
Net Income	91.89M
EBITDA	220.02M
EBIT	197.08M
Earnings Per Share (EPS)	1.71

Balance Sheet

The company has 139.45 million in cash and 865.39 million in debt, giving a net cash position of -725.93 million.

Cash & Cash Equivalents	139.45M
Total Debt	865.39M
Net Cash	-725.93M
Net Cash Per Share	n/a
Equity (Book Value)	519.02M
Book Value Per Share	9.73
Working Capital	259.12M

Cash Flow

In the last 12 months, operating cash flow was 184.74 million and capital expenditures -34.43 million, giving a free cash flow of 150.31 million.

Operating Cash Flow	184.74M
Capital Expenditures	-34.43M
Free Cash Flow	150.31M
FCF Per Share	n/a

Margins

Gross margin is 63.45%, with operating and profit margins of 19.30% and 9.00%.

Gross Margin	63.45%
Operating Margin	19.30%
Pretax Margin	13.73%
Profit Margin	9.00%
EBITDA Margin	21.55%
EBIT Margin	19.30%
FCF Margin	14.72%

Dividends & Yields

This stock pays an annual dividend of 0.77, which amounts to a dividend yield of 2.34%.

Dividend Per Share	0.77
Dividend Yield	2.34%
Dividend Growth (YoY)	3.06%
Years of Dividend Growth	n/a
Payout Ratio	44.20%
Buyback Yield	0.35%
Shareholder Yield	2.70%
Earnings Yield	6.02%
FCF Yield	9.85%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LON:0A5J has an Altman Z-Score of 2.14 and a Piotroski F-Score of 8. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.14
Piotroski F-Score	8